Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OncoC4, Inc.
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
Arcus Biosciences, Inc.
GlaxoSmithKline
Qurient Co., Ltd.
AstraZeneca
Poseida Therapeutics, Inc.
University of California, Irvine
AstraZeneca
ImmunityBio, Inc.
M.D. Anderson Cancer Center
HiFiBiO Therapeutics
BicycleTx Limited
SystImmune Inc.
Exelixis
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Cancer Research UK
Toray Industries, Inc
The Netherlands Cancer Institute
OncoC4, Inc.
Tempus AI
First Affiliated Hospital of Chongqing Medical University
Cybrexa Therapeutics
Carisma Therapeutics Inc
NextCure, Inc.
Shanghai PerHum Therapeutics Co., Ltd.
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
National University Hospital, Singapore
Comprehensive Support Project for Oncology Research
Adaptimmune